Ann: Investor Update, page-49

Hi Barnacles,

Received yesterday an email from Paul Anderson.

It was a link to a podcast interview Paul did with Alan Kohler last week.

So far I only listened half of the interview, as it goes on for 24 minutes.

What I have listened to so far, I am amazed that the share price of OCC is not at 5 dollars, today.

This is in My Opinion Only a game changer in the regenerative medicine space.

If investors are on the side line waiting and watching, better hurry up and buy up before the train departs the station.

Regards

Rossi70